0001104659-23-119090.txt : 20231116
0001104659-23-119090.hdr.sgml : 20231116
20231116160515
ACCESSION NUMBER: 0001104659-23-119090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231114
FILED AS OF DATE: 20231116
DATE AS OF CHANGE: 20231116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PETERS WILLIAM J
CENTRAL INDEX KEY: 0001263136
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 231414596
MAIL ADDRESS:
STREET 1: C/O AMPHASTAR PHARMACEUTICALS, INC.
STREET 2: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
tm2330835-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-11-14
0
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001263136
PETERS WILLIAM J
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
0
0
CFO, EVP & Treasurer
1
Common Stock
2023-11-14
4
M
0
21250
20.23
A
122610
D
Common Stock
2023-11-14
4
M
0
38000
13.03
A
160610
D
Common Stock
2023-11-14
4
S
0
14220
54.7626
D
146390
D
Common Stock
2023-11-14
4
S
0
30162
55.6728
D
116228
D
Common Stock
2023-11-14
4
S
0
14868
56.534
D
101360
D
Employee Stock Option (right to buy)
20.23
2023-11-14
4
M
0
21250
0
D
2029-03-15
Common Stock
21250
15225
D
Employee Stock Option (right to buy)
13.03
2023-11-14
4
M
0
38000
0
D
2030-03-16
Common Stock
38000
31100
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.15 to $55.145, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.16 to $56.15, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.17 to $56.81, inclusive.
Shares subject to the option are fully vested and immediately exercisable.
/s/ William J Peters
2023-11-16